Medindia LOGIN REGISTER
Medindia

FDA Warns Against Sexual Enhancement Supplements

by Sheela Philomena on March 25, 2013 at 2:14 PM
 FDA Warns Against Sexual Enhancement Supplements

Sexual enhancement supplements could pose danger as they contain hidden drugs, warns the US Food and Drug Administration. According to the FDA, a supplement called "Stiff Days" contains sildenafil, the active ingredient in prescription drug Viagra, which is used to treat erectile dysfunction; "Rock-It Man" contains a similar compound called hydroxythiohomosildenafil; and "Libido Sexual Enhancer" contains both of those ingredients as well as tadalafil, which is the active ingredient in the prescription drug Cialis, Fox News reported.

"These undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Men with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates," the agency said on its website.


The products are sold online and in some retail stores.

There is a growing trend in dietary supplements, often promoted for sexual enhancement, weight loss, and body building, to contain with hidden drugs and chemicals, although they are often represented as being "all natural," the agency said.

Consumers should be careful about purchasing such products, the FDA said, because the agency is unable to test and identify all products on the market that are marketed as dietary supplements but have potentially harmful hidden ingredients.

Source: ANI
Font : A-A+


Advertisement

Recommended Readings

Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Warns Against Sexual Enhancement Supplements Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests